Indaco Venture Partners SGR is the largest independent Italian venture capital asset management company, founded in 2016 and based in Milan. The firm specializes in companies innovating in electronics, robotics, new materials, medtech, biotech–pharma, and digital sectors, managing 7 funds totaling over €363 million.
Deal activity decreased year-over-year (1 deal in the last 12 months vs 2 prior). Average disclosed round size is $67.0M (across 3 rounds with reported amounts).
Portfolio
10
Fund Size
—
Top Stage
Unknown
Last 12 Mo
1
Team
Alvise Bonivento
Co-Founder Board Member Investment Director
Antonella Beltrame
Co-Founder Board Member Investment Director
Domenico Laudonia
Venture Partner
Giovanni Rizzo
Partner Indaco BIO Fund
Goncalo Rebelo De Andrade
Partner Indaco BIO Fund
Simone Zanolo
Venture Partner
Christian Saraullo
Investment Analyst
Federico Ferrari
Investment Analyst
Carlo Sanfilippo
Senior Investment Manager
Cosimo Calcagno
Senior Investment Manager
Elizabeth Robinson
Co-Founder Vice Chairman
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Newcleo | Unknown | $85M | Feb 2026 |
 IAMA Therapeutics | Series A | — | Apr 2025 |
 Newronika | Series B | — | Feb 2025 |
 D-Orbit | Series C | $110M | Jan 2024 |
 Enthera | Series A | — | Jan 2021 |
| EEnthera Pharmaceuticals | Series A | — | Dec 2020 |
 MainStreaming | Unknown | $6M | Jan 2019 |
| EEnthera Pharmaceuticals | Seed | — | Jan 2018 |
 Easyrain | Unknown | — | — |
 CYSEC | Seed | — | — |
| NNewlisi | Unknown | — | — |
Top Co-Investors
Last updated: 20 October 2026